Detalhe da pesquisa
1.
Ion channels in innate and adaptive immunity.
Annu Rev Immunol
; 33: 291-353, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25861976
2.
Delayed antiretroviral therapy in HIV-infected individuals leads to irreversible depletion of skin- and mucosa-resident memory T cells.
Immunity
; 54(12): 2842-2858.e5, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34813775
3.
RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics.
Nat Immunol
; 17(12): 1352-1360, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776107
4.
Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.
Nat Immunol
; 15(1): 88-97, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24165795
5.
Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies - impact of drug packaging and administration method on patient reported outcomes.
BMC Immunol
; 25(1): 18, 2024 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38378441
6.
Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment.
Genes Immun
; 24(1): 12-20, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517554
7.
Mosaic IL6ST variant inducing constitutive GP130 cytokine receptor signaling as a cause of neonatal onset immunodeficiency with autoinflammation and dysmorphy.
Hum Mol Genet
; 30(3-4): 226-233, 2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33517393
8.
Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study.
J Clin Immunol
; 43(6): 1259-1271, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036560
9.
Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies.
J Clin Immunol
; 43(7): 1557-1565, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37266769
10.
Real-World Evidence of Tolerability of 20% Subcutaneous Immunoglobulin Treatment.
J Clin Immunol
; 43(5): 912-920, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809598
11.
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.
J Clin Immunol
; 43(6): 1414-1425, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37160610
12.
Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home.
J Clin Immunol
; 43(6): 1360-1366, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145392
13.
Characteristics and Outcomes of Anti-interferon Gamma Antibody-Associated Adult Onset Immunodeficiency.
J Clin Immunol
; 43(7): 1660-1670, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365453
14.
A retrospective review of immunology patients with primary and/or secondary immunodeficiency, demonstrating the benefits of the rapid transitioning from intravenous immunoglobulin to subcutaneous immunoglobulin at the onset of the COVID-19 pandemic.
Intern Med J
; 53(7): 1256-1260, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092797
15.
A MultiCenter, OpenLabel, SingleArm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
J Clin Immunol
; 42(3): 500-511, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973143
16.
Long-Term Experience of Subcutaneous Immunoglobulin Therapy in Pediatric Primary Immunodeficient Patients with Low and Normal Body Weight.
J Clin Immunol
; 42(1): 64-71, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617265
17.
Plerixafor for the Treatment of WHIM Syndrome.
N Engl J Med
; 380(2): 163-170, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625055
18.
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
Clin Exp Immunol
; 210(2): 91-103, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208448
19.
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.
Hematol Oncol
; 40(3): 469-474, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076123
20.
Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease.
Vox Sang
; 117(10): 1153-1162, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944615